p62 Suppressed VK3-induced Oxidative Damage Through Keap1/Nrf2 Pathway In Human Ovarian Cancer Cells

Mei-Hui Xia1, Xiao-Yu Yan2, Lei Zhou3

  • 1Department of Obstetrics, the First Bethune Hospital of Jilin University, Changchun, Jilin, China.

Journal of Cancer
|February 13, 2020
PubMed

Insights

Overexpressed p62 protein protects ovarian cancer cells from vitamin K3 (VK3) induced oxidative damage by activating the Keap1/Nrf2 signaling pathway, suggesting a new therapeutic target.

Area of Science:

  • Biochemistry
  • Oncology
  • Cell Biology

Background:

  • Redox homeostasis imbalance is implicated in chemotherapy resistance in cancer.
  • Vitamin K3 (VK3) shows potential as an anti-tumor agent by promoting reactive oxygen species (ROS) production.

Purpose of the Study:

  • To investigate the role of p62 in mediating resistance to VK3 in ovarian cancer cells.
  • To elucidate the underlying molecular mechanisms involving the Keap1/Nrf2 signaling pathway.

Main Methods:

  • Comparison of VK3 sensitivity between SKOV3 and SKOV3/DDP ovarian cancer cells with differing p62 levels.
  • Analysis of Nrf2 downstream antioxidant gene expression (HO-1, NQO1) following VK3 treatment.
  • Investigation of p62 and Keap1 co-localization.
  • Assessment of apoptosis and gene expression changes upon p62 suppression.

Main Results:

  • SKOV3/DDP cells with high p62 levels exhibited insensitivity to VK3 compared to SKOV3 cells.
  • VK3 treatment upregulated Nrf2 downstream antioxidant genes (HO-1, NQO1) in SKOV3/DDP cells, indicating Nrf2 pathway activation.
  • Co-localization of p62 and Keap1 was observed.
  • Suppression of p62 enhanced VK3-induced apoptosis and downregulated Nrf2, HO-1, and NQO1 expression.

Conclusions:

  • Overexpressed p62 protects ovarian cancer cells against VK3-induced oxidative stress.
  • The protective effect is mediated through the activation of the Keap1/Nrf2 signaling pathway.
  • Targeting p62 may represent a novel strategy to overcome VK3 resistance in ovarian cancer.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.8K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.1K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
18.2K